在喘和COPD中戒烟的可治疗时刻:全国范围的队列研究
Delphine Vauterin1, Adam Edward Lang2, Kristiaan Proesmans1
1Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Gent, Belgium.
在患有肺部疾病的患者中,确定戒烟的可教训时刻至关重要. 严重的恶化和精神测量测试显著增加了试图戒烟的患者的可能性.
科学领域:
- 肺部医学 肺部医学
- 成 药物 药物 药物 药物
- 公共卫生 公共卫生
背景情况:
- 戒烟对于管理喘和慢性阻塞性肺病 (COPD) 等呼吸道疾病至关重要.
- 了解这些患者戒烟行为改变的特定"可学习时刻"仍然有限.
- 识别这些时刻可以优化对肺部疾病患者尼古丁依赖的干预措施.
研究的目的:
- 为了研究可能作为可治疗的禁烟时刻的健康事件,在患有喘或COPD的患者中.
- 确定特定的触发因素,增加了这种患者群体中戒烟尝试的可能性.
主要方法:
- 一项全国性队列研究分析了2017-2022年比利时行政卫生数据.
- 包括18岁以上的慢性肺病药物治疗和目前吸烟状态的患者.
- 多变量考克斯比例危险模型评估了健康事件对戒烟尝试 (咨询或药物) 的影响.
主要成果:
- 在94,788名患者中,13.2%试图戒烟.
- 严重的恶化 (aHR 1.82),抗抑郁药的使用 (aHR 1.70) 和与吸烟有关的癌症 (aHR 1.42) 显著增加了戒烟的尝试.
- 其他关键触发因素包括重症监护入院,螺旋计测试 (aHR 1.33),心肌梗塞 (aHR 1.32) 和中风 (aHR 1.28).
结论:
- 这项研究确定了阻塞性肺部疾病患者戒烟的重要可治疗时刻.
- 严重恶化和精神测量测试等事件与更高的戒断尝试的可能性有关.
- 这些发现超越了以前被认可的触发因素,如中风和心肌梗塞.
更多相关视频
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Asthma-III: Symptoms and Complications
Classification of Asthma
